Factors associated with mortality due to COVID-19 in patients from a public hospital in Tacna, Peru

Authors

  • Miguel Hueda-Zavaleta Facultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna, Perú.Hospital III Daniel Alcides Carrión, Tacna, Perú.Médico cirujano, especialista en Enfermedades Infecciosas y Tropicales https://orcid.org/0000-0002-8049-7787
  • Cesar Copaja-Corzo Facultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna, Perú.Centro de Investigación de Estudiantes de Medicina, Tacna, Perú.estudiante de Medicina Humana https://orcid.org/0000-0002-3497-0158
  • Fabrizzio Bardales-Silva Hospital III Daniel Alcides Carrión, Tacna, Perú.médico cirujano, especialista en Gastroenterología. https://orcid.org/0000-0001-9020-4426
  • Rodrigo Flores-Palacios Hospital III Daniel Alcides Carrión, Tacna, Perú.médico cirujano, especialista en Medicina Intensiva https://orcid.org/0000-0001-5374-7915
  • Luis Barreto-Rocchetti Hospital III Daniel Alcides Carrión, Tacna, Perú.químico farmacéutico, especialista en Farmacia Clínica https://orcid.org/0000-0002-2851-0219
  • Vicente A. Benites-Zapata Universidad San Ignacio de Loyola, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Lima, Perú.médico cirujano, maestro en Investigación Epidemiológica https://orcid.org/0000-0002-9158-1108

DOI:

https://doi.org/10.17843/rpmesp.2021.382.7158

Keywords:

COVID-19, SARS-CoV-2, Risk Factors, Pandemics, Viral Pneumonia, Coronavirus Infections, Hospitalization, Mortality, Survival, Peru

Abstract

Objective: To describe the clinical, laboratory and treatment characteristics of COVID-19 patients and to determine the factors associated with mortality during hospital stay. Materials and Methods: Retrospective cohort study of adult COVID-19 inpatients. The clinical, laboratory and treatment data were obtained from the medical records of patients from the Hospital Nivel III Daniel Alcides Carrión in Tacna. For the survival analysis we used the Cox proportional hazards model, and we calculated crude and adjusted hazard ratios (HR) with 95% confidence intervals (95% CI). Results: We evaluated 351 patients; 74.1% of them were men. The most common comorbidities were obesity (31.6%), hypertension (27.1%) and diabetes mellitus (24.5%). The median time of hospitalization was 8 days (IQR: 4-15). From the total of patients, 32.9% died during follow-up. The multivariate analysis showed an increased risk of dying associated with the following: age ≥65 years, HR = 3.55 (95% CI: 1.70-7.40); increase in lactate dehydrogenase >720 U/L, HR = 2.08 (95% CI: 1.34-3.22); and oxygen saturation less than 90%, mainly when it was less than 80%, HR = 4.07 (95% CI: 2.10-7.88). In addition, the use of colchicine during treatment showed a protective effect, HR = 0.46 (95% CI: 0.23-0.91). Conclusions: Risk factors for mortality due to COVID-19 included being older than 65 years, having oxygen saturation less than 90%, and elevated lactate dehydrogenase >720 U/L; colchicine treatment could improve the prognosis of patients.

Downloads

Download data is not yet available.

Published

2021-06-10

Issue

Section

Original Article

How to Cite

1.
Hueda-Zavaleta M, Copaja-Corzo C, Bardales-Silva F, Flores-Palacios R, Barreto-Rocchetti L, Benites-Zapata VA. Factors associated with mortality due to COVID-19 in patients from a public hospital in Tacna, Peru. Rev Peru Med Exp Salud Publica [Internet]. 2021 Jun. 10 [cited 2024 Jun. 12];38(2):214-23. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/7158

Most read articles by the same author(s)